International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-3 doi: 10.5281/zenodo.8006917
Original Article
Clinical Characteristics of Patients with Open Globe Injuries in Tertiary Care Centre
 ,
 ,
Published
June 5, 2023
Abstract
Background: Open Globe Injuries (OGIs) are severe ocular traumas that can result in significant visual impairment. A comprehensive understanding of the sociodemographic profile, causative factors, and clinical features is crucial to optimize management and prevention strategies. Methods: A prospective study was conducted at the Vijayanagar Institute of Medical Sciences, Bellary, from June to October 2022. The study included 30 cases of OGIs, with patients of all age groups. Patients with pre-existing ocular diseases affecting visual acuity were excluded. Results: The majority of the patients were males (76.7%) and children aged 0-9 years (40%). Most injuries occurred in rural settings (53.3%) and were predominantly caused by sticks (50%). Half of the patients presented with injuries to either eye. Initial visual acuity was predominantly hand motion perception (23.3%) or perception of light (20%). The most common corneal tear sizes were 4 mm (33.3%) and 8 mm (30%). Iris prolapse was observed in 53.3% of cases, while traumatic cataract was present in 66.7%. All patients required surgical intervention. Conclusion: OGIs present a significant clinical and public health challenge. Recognizing the demographics, common causative factors, and clinical characteristics is pivotal for developing effective preventive measures and improving patient outcomes.
Recommended Articles
Loading Image...
Volume-4, Issue-3
Citations
2882 Views
20 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved